Format

Send to

Choose Destination
J Speech Lang Hear Res. 2016 Oct 1;59(5):1247-1252. doi: 10.1044/2016_JSLHR-H-15-0363.

Patient-Reported Measures of Hearing Loss and Tinnitus in Pediatric Cancer and Hematopoietic Stem Cell Transplantation: A Systematic Review.

Author information

1
Section of Oncology and Cancer Research, Leeds Institute of Molecular Medicine, University of Leeds, United Kingdom.
2
Hematology/Oncology, Seattle Children's Hospital, WA.
3
Division of Paediatric Haematology/Oncology, Children's Hospital of Eastern Ontario, Ottawa, Canada.
4
Pediatric Audiology, Oregon Health and Science University, Portland.
5
Scholarly Communications and Researcher Skills, University of Leeds, United Kingdom.
6
E. M. Uleryk Consulting, Toronto, Ontario, Canada.
7
Dana-Farber/Boston Children's Cancer Center, MA.
8
Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada.

Abstract

Purpose:

We identified studies that described use of any patient-reported outcome scale for hearing loss or tinnitus among children and adolescents and young adults (AYAs) with cancer or hematopoietic stem cell transplantation (HSCT) recipients.

Method:

In this systematic review, we performed electronic searches of OvidSP MEDLINE, EMBASE, and PsycINFO to August 2015. We included studies if they used any patient-reported scale of hearing loss or tinnitus among children and AYAs with cancer or HSCT recipients. Only English language publications were included. Two reviewers identified studies and abstracted data.

Results:

There were 953 studies screened; 6 met eligibility criteria. All studies administered hearing patient-reported outcomes only once, after therapy completion. None of the studies described the psychometric properties of the hearing-specific component. Three instruments (among 6 studies) were used: Health Utilities Index (Barr et al., 2000; Fu et al., 2006; Kennedy et al., 2014), Hearing Measurement Scales (Einar-Jon et al., 2011; Einarsson et al., 2011), and the Tinnitus Questionnaire for Auditory Brainstem Implant (Soussi & Otto, 1994). All had limitations, precluding routine use for hearing assessment in this population.

Conclusions:

We identified few studies that included hearing patient-reported measures for children and AYA cancer and HSCT patients. None are ideal to take forward into future studies. Future work should focus on the creation of a new psychometrically sound instrument for hearing outcomes in this population.

PMID:
27603148
PMCID:
PMC5962920
DOI:
10.1044/2016_JSLHR-H-15-0363
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Atypon Icon for PubMed Central
Loading ...
Support Center